SP
Sheetal Paul
About Sheetal Paul
Data last updated:
Sheetal Paul is a Designated Partner at Bayleaf Biosciences Industries Llp (since 2022) and Director at Medismart Pharmaceutical Private Limited (since 2021). The companies operate in Business Services and Healthcare.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Designated Partner | 21 Feb 2022 | 2022 | Active | ||
| Director | 19 Jan 2021 | 2021 | Active |
Board colleagues of Sheetal Paul
| Name | DIN | Company | Designation |
|---|---|---|---|
| Minhaaz Momin | 09034620 | Bayleaf Biosciences Industries Llp , Medismart Pharmaceutical Private Limited | Designated Partner |
| Sumita Dutta Bhowal | 09211126 | Medismart Pharmaceutical Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sheetal Paul
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sheetal Paul
Sheetal Paul currently holds 2 directorships: Bayleaf Biosciences Industries Llp (Designated Partner, since 21 Feb 2022); Medismart Pharmaceutical Private Limited (Director, since 19 Jan 2021).
Sheetal Paul was first appointed on 19 Jan 2021 as Director at Medismart Pharmaceutical Private Limited. The most recent appointment on record is 21 Feb 2022 at Bayleaf Biosciences Industries Llp.
The current boards of Sheetal Paul's companies include Minhaaz Momin (Bayleaf Biosciences Industries Llp), Sumita Dutta Bhowal (Medismart Pharmaceutical Private Limited).